Biotech

All Articles

Vaxcyte rises on 'remarkable' 31-valent PCV succeed against Pfizer

.Vaxcyte revealed what experts named "impressive" stage 1/2 data for its own 31-valent pneumococcal ...

Recursion's brain illness trial reveals scant evidence of effectiveness

.Recursion has actually stumbled via a very early examination of its own tech-enabled technique to d...

Acepodia, Pfizer click on all together for chemistry-based cell therapy

.Call it a situation of excellent chemistry: Acepodia, a biotech based upon Nobel Prize-winning scie...

Praxis epilepsy medication reduces confiscations in phase 2 trial

.Praxis Accuracy Medicines has racked up yet another midphase gain in epilepsy this year, along with...

Three execs surrender as Dyne messages mixed records for DMD candidate

.After getting away from a professional grip many years back, Dyne Therapeutics has uncovered brand ...

Arrowhead fires off phase 3 records in uncommon metabolic illness in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has actually revealed its own hand before a potential showdown with Ionis...

Pfizer, Valneva show lyme illness go reliable for second enhancer

.Pfizer as well as Valneva might possess concerning pair of more years to stand by before they produ...

Fierce Biotech Editor-in-Chief Ayla Ellison Speaks Shop with Michelle Benz on the Future of Biotech.

.Let's study a chat along with Ayla Ellison, Brutal Biotech Editor-in-Chief as well as Michelle Benz...

New information show how Bayer's asundexian neglected to stop strokes

.Bayer put on hold the phase 3 trial for its own element XIa inhibitor asundexian behind time in 201...

Sanofi's tolebrutinib stops working 2 of 3 late-stage MS tests

.Sanofi is actually still set on taking its numerous sclerosis (MS) med tolebrutinib to the FDA, man...